Background Idiopathic pulmonary fibrosis (IPF) predominantly affects individuals aged> 60
years who have several comorbidities. Nintedanib is an approved treatment for IPF, which …

Background Myo-inositol (or inositol) and its derivatives not only function as important
metabolites for multiple cellular processes but also act as co-factors and second …

Body composition and muscle strength are emerging aspects in idiopathic pulmonary
fibrosis (IPF) clinical assessment. We aimed to study the relationships of handgrip strength …

Patients with idiopathic pulmonary fibrosis (IPF) often experience weight loss during the
follow-up period. However, the prevalence and clinical impact of weight loss in these …

Restrictive lung disease is defined as a reduction in lung volume that may be due to
intraparenchymal or extraparenchymal causes. Intraparenchymal causes falls under the …

Background Although genome-wide association studies (GWAS) have identified many
genomic regions associated with idiopathic pulmonary fibrosis (IPF), the causal genes and …

Pulmonary fibrosis (PF) is a severe pulmonary disease with limited available therapeutic
choices. Recent evidence increasingly points to abnormal lipid metabolism as a critical …

Introduction Idiopathic Pulmonary Fibrosis (IPF) is a rare disease that causes shortness of
breath, dry cough, and tiredness. While there is no cure for IPF, current therapeutic …

Objective To determine the effect of statins on risk of cancer in patients with interstitial lung
disease (ILD) and pulmonary fibrosis. Setting We retrospectively enrolled patients with ILD …

Background: The value of the phase angle (PhA), measured via bioelectrical impedance
analysis (BIA), could be considered a good marker of the cell mass and the cell damage of a …